analyst reports

09 AUG 2016

Bioshares - Edition 658. Early Signs of Efficacy and Clinical Relevance for Opthea's OPT-302

read more >>
11 JUL 2016

Bioshares - Edition 655. Opthea Approaches Important Trial Outcome

read more >>
22 APR 2016

Bioshares - Edition 644. Opthea's OPT-302 Passes Safety Checkpoint

read more >>
21 APR 2016

Bell Potter. Upgrade to Buy on Positive Phase 1 Results

26 FEB 2016

Bell Potter. Switching to Hold after solid run

05 FEB 2016

Bioshares – Edition 634. Results time approaching for Opthea

read more >>
18 DEC 2015

Bioshares – Edition 630. Top six stock picks – 2015 performance

read more >>
10 SEP 2015

Bell Potter – Initiation Report. We see value clearly

03 Jun 2014

Poster Presentation at ASCO

read more >>
07 May 2014

Poster Presentation at ARVO

read more >>
04 Nov 2013

The Association of Alternate VEGF Ligands with Resistance to Anti-VEGF Therapy in Metastatic...

read more >>
04 Jun 2013

VGX-100 Poster Presentation at ASCO

read more >>
08 Nov 2012

VGX-100 Poster Presentation at EORTC

read more >>
09 Mar 2012

Development of a Gene Expression Based Assay to Determine the Origin of Metastatic Carcinomas of...

read more >>
11 Sep 2011

VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling

read more >>
07 Jun 2011

VEGF-C and VEGF-D identified as biomarkers for Avastin resistance in colorectal cancer patients

read more >>
02 Apr 2011

The novel therapeutic monoclonal antibody VGX-100 neutralises VEGF-C and inhibits tumor growth and...

read more >>
17 Apr 2010

VGX-100, a novel therapeutic monoclonal antibody targeting VEGF-C that inhibits tumor growth

read more >>
25 Jun 2008

Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation

read more >>
01 Aug 2005

Inhibition of Lymphogenous Metastasis Using Adeno-Associated Virus-Mediated Gene Transfer of a...

read more >>
05 Jun 2002

Suppression of Tumor Lymphangiogenesis and Lymph Node Metastasis by Blocking Vascular Endothelial...

read more >>
01 Jan 1998

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2...

read more >>